Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. TMU Publications / 北醫出版品
  3. .博碩士學位論文
  4. 107學年度
  5. 去甲氯米帕明鹽酸鹽對上皮細胞間質轉化之肺癌細胞治療反應機制探討
 
  • Details
Options

去甲氯米帕明鹽酸鹽對上皮細胞間質轉化之肺癌細胞治療反應機制探討

Other Title
Study on the potential applications and mechanisms of desmethylclomipramine in mesenchymal transition lung cancer cell therapy
Type
thesis
Date Issued
2019-06-28
Author(s)
張祐宸
Advisor
陳嘉玲
Subjects
系所名稱:呼吸治療學系碩士班
Description
學位別:碩士
語文別:中文
指導教授:陳嘉玲
口試委員:林秋烽 Chiou-Feng Lin;陳炳常 Bing-Chang Chen;詹明修 Ming-Shiou Jan
電子論文連結:https://handle.ncl.edu.tw/11296/pvq7nv
URI
https://203.71.86.71/handle/123456789/60543

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback